Schuth Alexander O.'s Form 4 filing
Denali Therapeutics Inc. (DNLI) · filed Aug 6, 2021
- Accession no.
- 0001714899-21-000082
- Filed
- Aug 6, 2021
- Trade date
- Aug 4, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market sales total $522.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Schuth Alexander O.CIK 0001724311 | Officer (COO and Secretary) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 4, 2021 | Common Stock | SSaleDisposed | −1,564 | $51.52F2 | −$80,577.28 | 490,018 | Indirect | |
| Aug 4, 2021 | Common Stock | SSaleDisposed | −8,236 | $52.34F4 | −$431,072.24 | 481,782 | Indirect | |
| Aug 4, 2021 | Common Stock | SSaleDisposed | −200 | $52.99 | −$10,598 | 481,582 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $50.93 to $51.92 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F4
The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $51.93 to $52.84 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.